NASH WITH FIBROSIS

Clinical trials for NASH WITH FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new NASH WITH FIBROSIS trials appear

Sign up with your email to follow new studies for NASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New combo targets 'Zombie Cells' to fight liver scarring

Disease control Completed

This study tested whether a combination of two drugs, dasatinib and quercetin, could reduce liver scarring (fibrosis) in people with fatty liver disease. Thirty adults with confirmed liver scarring participated in this early-stage trial. The goal was to see if clearing certain ag…

Matched conditions: NASH WITH FIBROSIS

Phase: PHASE1, PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

NASH WITH FIBROSIS

Get alerted when new NASH WITH FIBROSIS trials appear

New combo targets 'Zombie Cells' to fight liver scarring